Loading stock data…
Henry Schein (HSIC)
$85.47+0.94 (+1.11%)
Market ClosedLast close Jul 24
Henry Schein, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Henry Schein, Inc. in the Healthcare sector is trading at $85.47 with a market capitalization of $9.3B. Wall Street consensus targets $88.50 (16 analysts), implying a +3.5% move over the next 12 months. The stock is currently near its 52-week high of $89.34, remaining 12.8% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.37B↓ | $3.44B↑ | $3.34B↑ | $3.24B↑ | $3.17B |
| Gross Profit | $1.07B↑ | $1.06B↑ | $1.03B↑ | $1.02B↑ | $1.00B |
| Operating Income | $194.00M↑ | $186.00M↓ | $198.00M↑ | $174.00M↓ | $200.00M |
| Net Income | $107.00M↑ | $101.00M | $101.00M↑ | $86.00M↓ | $110.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$9.32B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
12.09%
Volume
Today's trading volume
1.07M
Recent News
Are Investors Undervaluing Henry Schein (HSIC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Henry Schein (HSIC) Could Be 3% Undervalued As Earnings Come Into Focus
Upcoming earnings release puts focus on Henry Schein stock Henry Schein (HSIC) is back on investors’ radar after announcing it will report second quarter 2026 results before the market opens on August 4, followed by an earnings conference call and webcast. See our latest analysis for Henry Schein. Henry Schein’s recent share price performance has been firmer over the past few months, with a 30 day share price return of 7.43% and a year to date share price return of 11.77%. Meanwhile, the 1...
Will Henry Schein (HSIC) Beat Estimates Again in Its Next Earnings Report?
Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Profitable Stocks Walking a Fine Line
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
What to Expect From Henry Schein's Next Quarterly Earnings Report
Henry Schein will release its second-quarter earnings soon, and analysts anticipate a low double-digit bottom-line growth.